Huntleigh Advisors Inc. Raises Stock Position in Addus HomeCare Corporation $ADUS

Huntleigh Advisors Inc. grew its holdings in Addus HomeCare Corporation (NASDAQ:ADUS) by 5.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,971 shares of the company’s stock after buying an additional 213 shares during the period. Huntleigh Advisors Inc.’s holdings in Addus HomeCare were worth $457,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Addus HomeCare in the 1st quarter worth about $41,000. CWM LLC lifted its holdings in shares of Addus HomeCare by 25.3% in the 2nd quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after acquiring an additional 112 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company’s stock worth $124,000 after acquiring an additional 987 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of Addus HomeCare by 26.4% in the 2nd quarter. GAMMA Investing LLC now owns 1,673 shares of the company’s stock worth $193,000 after acquiring an additional 349 shares during the last quarter. Finally, Bailard Inc. bought a new stake in shares of Addus HomeCare in the 1st quarter worth about $208,000. Institutional investors own 95.35% of the company’s stock.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of the company’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the completion of the transaction, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. This represents a 11.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the sale, the director directly owned 5,067 shares of the company’s stock, valued at $582,350.31. The trade was a 23.67% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,310 shares of company stock worth $3,958,375. Company insiders own 4.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on ADUS shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Stephens reiterated an “overweight” rating and set a $140.00 price objective on shares of Addus HomeCare in a report on Wednesday, September 3rd. TD Cowen lifted their price objective on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. UBS Group started coverage on shares of Addus HomeCare in a report on Tuesday, September 2nd. They set a “buy” rating and a $145.00 price objective for the company. Finally, Wall Street Zen raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Sunday, June 29th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $137.50.

Addus HomeCare Stock Up 1.0%

NASDAQ:ADUS opened at $118.31 on Friday. The company has a market cap of $2.18 billion, a PE ratio of 26.12, a P/E/G ratio of 1.80 and a beta of 0.86. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17. The company’s 50 day moving average is $114.10 and its two-hundred day moving average is $110.59.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $349.44 million during the quarter, compared to analysts’ expectations of $345.71 million. During the same period in the previous year, the business posted $1.35 EPS. The business’s quarterly revenue was up 21.8% compared to the same quarter last year. Analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.